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Abstract
Background: After a lesion to the central nervous system, many patients suffer from reduced walking capability. In
the first rehabilitation phase, repeated walking exercises facilitate muscular strength and stimulate brain plasticity
and motor relearning. However, marked limping, an unsteady gait, and poor management of obstacle clearance
may persist, which increases a patient’s risk of falling. Gait training with augmented reality has been recommended
to improve gait coordination. The objective of this study is to test whether a gait rehabilitation program using
augmented reality is superior to a conventional treadmill training program of equivalent intensity.
Methods/design: The GASPAR trial (Gait Adaptation for Stroke Patients with Augmented Reality) is a pragmatic,
parallel-arm, single-center, nonblind, superiority randomized control trial in neurorehabilitation. The setting is a
rehabilitation clinic in Switzerland. The planned number of participants is 70–100. The intervention uses
instrumented treadmills equipped with projectors that display shapes on the walking surface. The principle is that
patients must adapt their gait to the image that unfolds in front of them. Specific exercises for gait symmetry,
coordination enhancement, and gait agility are provided. The program includes twenty 30-min sessions spanning
4 weeks. The comparator group receives standard treadmill training of a similar frequency and intensity. The main
outcome to be measured in the trial is walking speed, which is assessed with the 2-min Walk Test. Moreover, gait
parameters are recorded during the gait training sessions. Other outcomes are balance control (Berg Balance Scale)
and the fear of falling (Falls Efficacy Scale). The statistical analyses will compare the baseline assessment for each
participant (before the intervention) with a post-intervention assessment (taken a few days after the end of the
program). Furthermore, a follow-up assessment will take place 3 months after discharge.
Discussion: The study results will provide new knowledge about recovery in neurological patients and will
contribute to the design of better rehabilitation programs to accompany this process. The findings will also help
health care funders to decide whether treadmills equipped with augmented reality capabilities are a worthwhile
investment.
Trial registration: ClinicalTrials.gov ID: NCT02808078, registered on 16 June 2016.
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Background
In high-income countries, strokes are the third leading
cause of death after cardiovascular diseases and cancers.
In Switzerland, about 16,000 people suffer a stroke each
year [1]. However, over the last few decades, the death
rate following strokes has continuously declined in de-
veloped countries because of improvements in primary
care. The corollary to this trend is an increased burden
on rehabilitation units because of stroke survivors with
severe disabilities [2]. The major long-term disability
that hinders stroke survivors in recovering a normal life
is partial paralysis affecting the extremities. Six months
after a stroke, 50 % of stroke survivors still suffer some
degree of hemiparesis and 30 % are unable to walk
without assistance [3].
In addition to strokes, other circumstances that damage
neural tissue can induce similar disabilities. Traumatic
brain injuries (TBI), most commonly induced by falls or
road traffic accidents, are also a significant issue in
Switzerland, with about 850 severe cases per year [4]. Pa-
tients with traumatic spinal cord injuries (SCI), represent-
ing about 150 cases per year, can be added to this number
[5]. Roughly 50 % of these patients suffer from incomplete
injuries and thus exhibit residual locomotor capacities [6].
During the months following an injury to the central
nervous system, patients partially recover motor and
sensory patterns that were in place before the injury. In
stroke patients, the maximum degree of recovery typic-
ally occurs within the first 3 months, then it progresses
at a slower rate until 6 months have passed [7]. This re-
covery process is in part driven by brain plasticity. In
short, redundant connectivity exists in the brain, and
new functional circuits can form via remapping between
cortical regions [8, 9]. It has been shown that providing
an enriched environment stimulates plasticity and facili-
tates recovery [9]. Although further studies are needed
to better understand brain plasticity in humans [10],
neurorehabilitation is largely based on the premise that
a set of well-chosen exercises can stimulate neural plas-
ticity and enhance the recovery process.
The following are general guidelines for early neuroreh-
abilitation [11]: (1) care provided by a multidisciplinary
team, working together in close cooperation to improve a
patient’s independence, (2) task-specific training, in which
specific functional tasks are practiced repeatedly, and (3)
high-intensity practice. This approach applies to both
stroke survivors and TBI patients [12]. It is likely that, in
the case of stroke survivors specifically, strength training,
overground walking training, and speed-dependent tread-
mill training can improve aspects of gait [13–16]. To be
effective, walking training should occur with an average
frequency of 3–5 times weekly, in sessions lasting from 20
to 60 min [15]. Concerning patients with incomplete SCI,
strong evidence also exists that repeated walking exercises
enhance locomotor recovery [6]. Specifically, task-oriented
physiotherapy and manual/robotic treadmill training with
bodyweight support have been recommended to stimulate
brain plasticity [17].
A favorite target for neurorehabilitation is dynamic
and static balance. Patients with gait disorders of neuro-
logical etiologies are prone to frequent falls [18–20].
Such falls are induced by altered gait coordination which
reduces the patient’s adaptability to environmental
demands. A major cause of coordination deficit is asym-
metry in the propulsive forces between limbs. Altered
proprioception [21], gait ataxia, and vestibular disorders
[22] may also induce coordination issues. Balance con-
trol can also be compromised because of poor central
integration of sensory inputs [23]. Although classical in-
terventions have been shown to improve walking speed
[16], asymmetric gait patterns and poor coordination
may persist [24]. Different approaches have been pro-
posed to improve gait coordination in these patients,
such as task-specific walking practice, ankle-foot
orthoses, and functional electrical stimulation [25].
Meta-analyses have shown that the best method for
training gait coordination in stroke patients is auditory
cueing [13, 25]. In this therapy, patients must
synchronize their steps with rhythmic auditory stimuli
given at a pace that corrects temporal asymmetries of
the gait pattern. A recent systematic review has shown
that the addition of 30 min of cueing cadence to gait
training, four times a week for 4 weeks, is likely to im-
prove the walking ability of stroke patients [26].
In the last decade, the use of visual cues in interven-
tions aimed at improving gait coordination has been
proposed. In a manner similar to auditory cueing, the in-
tent of these visual cues is to encourage patients to walk
with a more symmetrical gait pattern. The use of aug-
mented reality (AR), i.e., the projection of shapes over
the walking surface of treadmills, can also serve to exer-
cise gait agility. It has been proposed that gait adaptability
can be increased through a specific program in which
visual cues are projected to trigger step adjustments (e.g.,
target stepping, obstacle avoidance) [27]. Preliminary re-
sults in a limited number of chronic stroke patients have
shown that visually-guided gait training improved walking
speed, balance, and the level of physical activity [27]. The
underlying neurophysiological mechanisms for such im-
provement may be that this type of program allows for
better exploitation of alternate sensory modalities to pro-
vide feedback regarding the ongoing movement. In
addition, it cannot be excluded that stimulating the brain
with an enriched visual environment related to the trained
task stimulates neural plasticity. Finally, offering a variety
of gait exercises may increase a patient’s motivation.
Despite these promising findings, the lack of large clinical
trials to date prevents us from drawing definitive
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conclusions about the usefulness of visually-guided step-
ping for gait rehabilitation.
Trial objectives
The main goal of the GASPAR (Gait Adaptation for
Stroke Patients with Augmented Reality) trial is to assess
the efficacy of a treadmill training program that uses
visually-guided stepping (AR) during the first phase of
rehabilitation for patients with neurological gait disor-
ders following a stroke. In addition, by the use of a prag-
matic design, we seek to increase the generalizability and
applicability of the study’s potential findings [28]. Conse-
quently, in order to reflect the typical population in a
neurorehabilitation center, we include patients with gait
disorders of different etiologies; i.e., in addition to stroke
patients, the study includes SCI and TBI patients who
need gait rehabilitation. The AR program aims at three
therapeutic goals: (1) to improve walking speed, which is
important to ensure the independence of the patients in
their daily lives, (2) to correct gait asymmetry, which
may lead to their recovery of a more functional and
physiological gait, thus improving gait coordination and
reducing their risk of falls, and (3) to exercise gait agility,
which may enhance patients’ adaptability to environmen-
tal changes while walking and hence again reduce fall
risks. We also focus on assessment of the efficiency of the
AR intervention. Specifically, we seek to document the pa-
tients’ adherence to, and compliance with, the program
and to assess their tolerance for AR walking.
Methods/design
Trial design
The GASPAR trial is a pragmatic, parallel-arm, single-
center, nonblind, superiority randomized control trial in
neurorehabilitation. The main objective is to test
whether a 4-week gait rehabilitation program that uses
AR is superior to a conventional treadmill training
program of equivalent intensity. The participants’ flow is
shown in Fig. 1, and the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
schedule [29] is given in Table 1. Baseline assessments
(T0) are taken prior to allocation, which consists of
blocking randomization (2:1 ratio) with stratification ac-
cording to disease etiology. Post-intervention assess-
ments of the two groups (T1) serve to compare the
short-term efficacy of the different interventions. Three
months after discharge, follow-up assessments (T2) take
place to detect potential long-term effects.
Setting
The study takes place in the Clinique Romande de Ré-
adaptation (CRR, Sion, Switzerland). This clinic offers
145 beds and is one of the main rehabilitation centers in
western Switzerland (with its 2.1 million inhabitants).
Because of its affiliation with the accident insurance
company SUVA, the CRR is a common referral center
for traumatic injuries, especially for SCIs. The overall
objective of the CRR’s therapeutic program is to take
care of patients through a multidisciplinary approach to
improve their quality of life, functional status, and
chance of returning to work. The number of hospitalized
patients at the CRR is about 1200 per year, with an aver-
age stay of 40 days. Recruitment for this study began in
June 2016. A 2-year framework is planned for the study,
with possible adjustments according to the results of the
interim analyses (see below).
Participants
Study participants will be recruited from among the in-
patients admitted for neurorehabilitation at the CRR. Se-
lection of the inclusion criteria was guided by the
Fig. 1 Flowchart of the Gait Adaptation for Stroke Patients with
Augmented Reality (GASPAR) trial
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rationale of reflecting the prevailing choice in neuroreh-
abilitation clinics of specific therapies that are tailored to
patients’ needs. A summary of the inclusion/exclusion
criteria is shown in Table 2. Potential candidates will be
monitored during their first 3 weeks after admission
(Fig. 1). Motor functions will be assessed by a skilled
neurologist, who will evaluate the need for gait rehabili-
tation. If and when the candidate is able to walk during
a 2-min test, a final decision for inclusion will be made.
Those candidates who do not exhibit sufficient walking
capacities after 3 weeks will be excluded.
Assignment of interventions and blinding
Assignment is effected by a block randomization proced-
ure with varying block size, implemented by independ-
ent researchers not affiliated with the GASPAR study.
The STATA package RALLOC [30] is used to generate
the sequences. The ratio between the intervention and
the control group is 2:1; this facilitates recruitment [31]
and provides a broader range of information and experi-
ence about the AR program. In addition, stratification is
made according to the type of injury: stroke patients,
TBI patients, and SCI patients. This procedure ensures
Table 1 Schedule of enrollment, interventions, and assessments according to the SPIRIT guideline







Time (week) −3 to −1 0 1 2 3 4 5 15 w after discharge




Allocation (after T0) x
Gait training (Intervention) x x x x
Walking speed (2-min Walk Test) x x
Balance (BBS) x x
Gait parameters x x x x
Compliance and motivation (questionnaire) x x
Fear of falling (FES) x x
Falls Diary x
Quality of life SF-36 x
Concomitant therapy (usual care for inpatients) x x x x x x x
Adverse events x x x x x x
BBS Berg Balance Scale, FES Falls Efficacy Scale, SF-36 Short Form 36-item questionnaire, w week
Table 2 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Patient with stroke, traumatic brain injury, or spinal cord injury in acute
to subacute phase
Age <18 years
First stage of rehabilitation (<40 days after incident) Clinically significant concomitant disease states (e.g., cardiovascular disease)
that may threaten the patient’s health in case of sustained exercise
Need for gait rehabilitation because of at least one of the following
conditions:
• Paresis of the lower extremities
• Severe balance disorders
• No walking at admission
Concomitant gait disorders induced by acute to subacute musculoskeletal
injuries (e.g., fracture of the lower extremities)
Ability to walk for 2 min without aid or with minimal aid, namely:
• With the help of one person, or:
• With walking aid (cane, walker)
Severe preexistent gait disorders that deeply affect walking abilities and gait
pattern, either because of musculoskeletal (e.g., severe osteoarthritis)
or neurological (e.g., Parkinson’s disease) etiologies
Informed consent as documented by signature Severe noncorrected visual impairment.
Inability to follow the procedures of the study, e.g., because of language
problems, psychological disorders, dementia, etc.
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the comparator and treatment groups to be populated
by patients with comparable disease etiologies and thus
facilitates interpretation of the results. Sequentially num-
bered, opaque, sealed envelopes are used to conceal the
allocation. Informed consent is obtained by the principal
investigator or his/her delegate. Inclusion is confirmed
by the referring neurologist. After baseline assessments
are taken (T0), the sealed envelope is opened to allocate
the participant.
Given the nature of the intervention and its clinical
setting, masking is not possible. However, the use of an
objective measure as the primary outcome minimizes
the risk of bias.
Medical devices
The intervention uses two different treadmills:
1. The FDM-T treadmill (Zebris Medical, Isny im
Allgäu, Germany): this treadmill is equipped with a
grid of 10,000 capacitive sensors aimed at analyzing
foot pressure (200-Hz sampling rate). The walking
surface is 170 × 65 cm. Handrails and a harness
ensure optimal safety even for frail individuals. A
wide-angle projector (beamer) situated in front of
the belt projects stepping targets for the purpose of
visual gait training. The Zebris treadmill has been
successfully used for gait rehabilitation in patients
with Parkinson’s disease [32]
2. The C-Mill treadmill: this treadmill (MotekForce
Link, Doorn, The Netherlands) is equipped with an
embedded 70 × 300 cm vertical force platform. The
long walking surface allows users to exercise gait
agility in varying positions along the belt. The
treadmill records the vertical force and the position
of the center of pressure at a sampling rate of
500 Hz. A projection system displays visual objects
on the walking area from the right side of the
treadmill. Three recent studies have highlighted the
potential of the C-Mill treadmill for stroke
rehabilitation [27, 33, 34]
Intervention
The intervention consists of 20 gait training sessions
over 4 weeks. Each training session lasts 30 min. The
first 10 sessions (2 weeks) use the Zebris treadmill for
basic training of walking speed, step length, and gait
symmetry. In the last 2 weeks (10 sessions), the C-Mill
treadmill is used for training that is more oriented to-
ward gait agility:
1. Zebris sessions: the gait training performed on the
Zebris treadmill aims at improving walking speed,
step length, and gait symmetry. The 30-min session
begins with a 1-min warmup used to record gait
parameters. Then, 5 × 5-min walking intervals are
proposed to the participant, punctuated by breaks of
30 s to 1 min. In the first interval, the patient must
simply synchronize his/her steps with visual targets
(“stepping stones”) based on the gait parameters
recorded during the warmup. Then, two types of
training are proposed according to the patient’s
needs: (1) symmetry training, where the stepping
stones are progressively adapted toward a more
symmetrical pattern, and (2) step-length training, in
which the stepping stones are progressively adapted
to present longer steps to the participant. Finally, a
1-min walk without stepping stones is performed at
the end of the session to evaluate the immediate
effect of the session on the patient’s gait parameters
2. C-Mill sessions: C-Mill sessions aim at training gait
agility, that is, speed adaptation and obstacle avoidance.
Similar to the Zebris session, the 30-min C-Mill session
is divided into 5 × 5-min walking intervals, preceded by
a 1-min warmup and followed by a 1-min final assess-
ment. The first interval is dedicated to symmetry or
step-length training; the stepping stones are adjusted to
provide asymmetry correction or longer steps. In the
second interval, the participant must continuously
adjust his/her steps to random variations in the
position of the stepping stones (varying step length).
During the third interval, the patient follows a target
area that moves back and forth over the entire length
of the treadmill, requiring coordinated speeding up and
slowing down. The fourth interval is similar, but with
increased difficulty (higher acceleration). Finally,
training that includes obstacle avoidance is proposed:
unilateral and bilateral obstacles are projected in front
of the participant, who must step over them. The speed
at which the intervals are performed is kept constant
throughout one session, but is progressively increased
from one session to another.
The intervention is tailored to the needs and capacity
of each participant. For instance, fatigue might make it
impossible for a patient to walk for the targeted 25 min,
or a frail patient might not make sufficient progress to
use the C-Mill after 2 weeks on the Zebris treadmill.
Conversely, higher-functioning patients might benefit
from C-Mill treatment earlier. The number of intervals
performed in each session and the exact training pro-
gram are documented and taken into account in the
statistical analysis.
Comparator
The choice of intervention for the comparator group re-
flects a balance between the ethical obligation to provide
efficient therapy to all participants and the requirement
of standardization to specifically assess the efficacy of
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AR gait training. Therefore, we exercise participants in
the comparator group with the same treadmills and with
comparable frequency and intensity to the participants
in the intervention group, but without the AR. The
walking exercises consist of a progressive speed increase
within and between the sessions.
Concomitant treatments
The interventions are fully integrated into the CRR’s
therapeutic program, which includes individual and
group therapies (exercises, joint mobilization, speech re-
habilitation, etc.) every weekday for a mean time of
2.5 h. The participants in the study follow the usual
schedule of care, except that some of the routine physio-
therapy sessions are replaced by the study interventions.
Study outcomes
The selection of the outcomes was guided by three
criteria: (1) importance for the patient, (2) ease of imple-
mentation in a clinical context, and (3) validity to assess
the recovery of locomotor function and gait coordin-
ation. A summary of the selected outcomes and their
specific aims is presented in Table 3. The principal out-
come is walking speed, which is a widely used index in
research and in rehabilitation clinics [16]. Furthermore,
speed is a good predictor for a patient’s independence
during daily life activities [7, 15]. As additional indexes
of walking ability, we collect gait data during every train-
ing session, taking advantage of the embedded sensors
in the treadmills. Typical spatiotemporal parameters are
measured: step length, step width, step time, stance
phase duration (percentage of gait cycle), and swing
phase duration (percentage of gait cycle). Moreover,
spatial and temporal left/right asymmetries and stride-
to-stride variability are assessed. Recording gait parame-
ters on a daily basis will allow for detailed analysis of the
participants’ evolution during the intervention. Other
outcomes are related to balance and fall risk, such as the
Berg Balance Scale (BBS), a falls efficacy question-
naire (FES), and a Falls Diary after discharge. The assess-
ments (T0, T1) are performed by skilled therapists as
part of usual care. Finally, the patients’ subjective per-
ceptions of the intervention and their quality of life at
home 3–4 months after discharge are also investigated.
Data management follows the clinical practices recom-
mended by the ISO:14155 standard.
Sample size
An interim analysis based on 30 participants with
complete data will be conducted to perform a power
analysis and to compute the final sample size. The
current estimation (as of June 2016) is that a total of 70
to 100 participants will be recruited. The reasons for
such an approach are as follows: the hospitalization sta-
tistics for the years 2014 and 2015 show that about 300
patients per year were admitted for neurorehabilitation
at the CRR, of which 70 were acute to subacute patients.
Retrospective analyses of medical files over recent years
indicate that 35–50 patients per year would have been
eligible for the study: 20–25 stroke patients, 10–15 TBI
patients, and 5–10 SCI patients. As a result, approxi-
mately 70–100 eligible candidates are expected over the
2-year framework of the study. The uncertainty of this
number results from the substantial year-to-year vari-
ability seen in patients’ profiles. A preliminary power
analysis is not possible for two reasons: (1) the data cur-
rently available in the literature about walking speed in
acute to subacute TBI and SCI patients are sparse and
inconsistent, and (2) while more studies report changes
in walking speeds in stroke patients [35], a substantial
heterogeneity exists concerning the time of measure-
ment and inclusion criteria for these studies. As a result,
we do not have yet sufficient information to estimate the
variance of our principal outcome. Consequently, we
Table 3 Trial outcomes
Outcomes Assessments Objectives
Walking speed 2-min Walk Test [36] To estimate the overall effect of intervention
on walking abilities
Gait parameters Spatiotemporal parameters (including
symmetry) measured by the instrumented
treadmills
To measure participant’s gait in each training
session for analyzing longitudinally the evolution
of walking abilities
Balance Berg Balance Scale (BBS) [37] To estimate the effect of intervention on static balance
Fear of falling Questionnaire: adapted Falls Efficacy Scale
(FES) [38]
To assess the participant’s confidence in performing
daily living activities that require balance control
Falls Falls Diary completed by the participant over
the 3–4 months following discharge
To measure effective fall rate at home
Perception of the intervention Ad-hoc questionnaire (tailor-made survey) To evaluate the patient’s subjective perception of the
intervention
Quality of life Questionnaire: Short Form 36-item (SF-36)
questionnaire [39]
To obtain an overall survey of wellbeing and quality of life
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plan to assess the variance of the outcomes and the ef-
fect sizes with an interim analysis based on 30 subjects.
The definitive sample size will be assessed accordingly.
Statistical analysis
Statistical analyses will be supervised by a skilled statisti-
cian and performed with MATLAB and STATA. We will
analyze all randomized participants for whom the T1 as-
sessment of the primary outcome and at least one training
session are available (i.e., the “intention-to-treat”
principle). The interim analysis, including 30 participants,
will guide the final statistical methodology. The short-
term efficacy of the intervention will be analyzed using the
changes between T1 and T0. As the null hypothesis, we
postulate that the change before and after the intervention
(T1–T0) will not differ between the two groups. We will
use simple comparison tests (t tests) and multiple
regressions; in this case, intervention intensity (number of
training sessions), disease etiology, and age will be used as
covariates. Furthermore, we will longitudinally analyze
(linear growth model) the gait parameters recorded in
each gait training session; we hypothesize (H0) that the
change over time will be equivalent between groups. We
will also assess the difference between groups for the out-
comes that are measured at T2 (3-month follow-up). Fi-
nally, as a subgroup analysis, we plan to analyze stroke
survivors, TBI, and SCI patients separately.
Safety and confidentiality
Fall risks in frail patients are inherent to walking prac-
tice. However, the benefits of high-intensity training far
outweigh the consequences of an isolated fall. We take
several safety measures to mitigate fall risks during the
intervention. The participants are constantly supervised
by skilled therapists during the interventions and assess-
ments. The participants can use handrails to stabilize
their gait during the treadmill intervention. The inter-
vention always begins with the Zebris treadmill, which is
equipped with a safety harness; the participants continue
with the C-Mill treadmill only if their gaits are suffi-
ciently stabilized.
Other potential burdens may include physical fatigue
and muscle pain because of the repetitive practice of
exercises. Although this is an inevitable consequence of
gait rehabilitation, we will take into account the com-
plaints of the patients by modulating the intensity and
frequency of the training sessions. Finally, it cannot be
totally excluded that participants in the AR intervention
may experience dizziness or vertigo, especially if they
have balance disorders. This effect has never been re-
ported in the literature, but we are ready to document
and account for this potential adverse event.
Individual subject medical information obtained as a
result of this study is considered confidential, and dis-
closure to third parties is prohibited. During the trial,
confidentiality is ensured by utilizing subject identifica-
tion code numbers. In the final stage of the study, a full
anonymization procedure will be conducted to build the
final database. All participants are specifically informed
about this procedure.
Discussion
Particular attention has been paid to the study’s pragmatic
design, to ensure that it guarantees high generalizability
Table 4 PRagmatic Explanatory Continuum Indicator Summary (PRECIS-2) scores of trial domains
Domain Score Rationale
1 Eligibility criteria 3 P: inclusion of patients with gait disorders whatever the etiology
E: focus on acute to subacute patients in first phase of rehabilitation
2 Recruitment path 4 P: recruitment of participants through usual clinical care at admission
E: specific procedures to assess eligibility (3 weeks of monitoring)
3 Setting 3 P: study takes place in a neurorehabilitation unit
E: single-center trial in a high-income country
4 Organization intervention 5 P: resources, provider expertise, and organization of care delivery in
both study arms are similar to usual care
5 Flexibility of experimental intervention:
delivery
5 P: identical flexibility to usual care
6 Flexibility of experimental intervention:
adherence
5 P: no more than usual encouragement to adhere to the intervention
7 Follow-up 4 P: assessment of outcomes through usual clinical care
E: specific procedure for follow-up after discharge
8 Outcome 5 P: outcomes are of obvious importance to participants and caregivers
9 Analysis 5 P: intention-to-treat analysis with all available data
Score: 1 Very explanatory; 2 Rather explanatory; 3 Equally pragmatic/explanatory; 4 Rather pragmatic; 5 Very pragmatic. P pragmatic, E explanatory
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and yields useful findings. We evaluated protocol design
according to the rating grid proposed by the PRagmatic
Explanatory Continuum Indicator Summary (PRECIS)-2
guidelines [28] (Table 4). The average score among the
nine PRECIS domains is 4.33, which indicates a rather
pragmatic protocol. Issues that tend to lower the score
are: (1) the focus on a subpopulation of neurologic
patients, and (2) the fact that the trial takes place in a sin-
gle center with some particularities (high-income country,
over-representation of traumatic patients).
We hope that the study’s findings will provide know-
ledge about recovery in neurological patients and help in
designing better rehabilitation programs to accompany
this process. In particular, the instrumented treadmills
will collect a large amount of gait data, which is of inter-
est for further research in neurorehabilitation. Practi-
tioners will benefit from new information for tailoring
gait interventions to the needs of their patients. Finally,
the results will also help health care funders to decide
whether using treadmills equipped with AR capabilities
is a worthwhile investment.
Trial status
The GASPAR trial began recruitment in June 2016.
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